NTD 400 400mg/ml 10ml Vial by GenTec

Usage

1. Confirm blast-phase readiness: obtain baseline blood work (testosterone, oestradiol, prolactin, LH, FSH, haematocrit) before starting NTD 400 to establish reference values for mid-cycle monitoring.
2. Warm the vial: hold the sealed NTD 400 vial in your hands for 60–90 seconds or briefly place it in warm (not hot) water to reduce oil viscosity — this improves drawability at 400mg/ml concentration.
3. Draw with a large-bore needle: use a 21G needle to aspirate the required volume into the syringe, then swap to a 23–25G injection needle to minimise tissue trauma at the injection site.
4. Select and rotate injection sites: glutes and ventro-glutes are the preferred primary sites for oil volumes above 1ml; rotate systematically across sites on a twice-weekly schedule (e.g. Monday left glute, Thursday right glute) to prevent localised fibrosis.
5. Administer and monitor: inject slowly (over 20–30 seconds per ml), apply gentle pressure post-injection. Log injection date, site, and volume; track bodyweight, strength, and subjective wellbeing weekly to assess blast-phase response.
6. Plan PCT in advance: mark the date of your final injection and count forward 14–21 days — have your full PCT protocol (SERM + prolactin agent) prepared and on hand before the blast cycle begins, not after.

Warnings

Frequently asked questions

What does a standard PCT look like after a blast cycle run with NTD 400?

PCT should begin approximately 14–21 days after the last NTD 400 injection, timed to the clearance of Nandrolone Decanoate — the longest-acting ester in the blend (~12-day half-life). A standard protocol combines a SERM (e.g. Nolvadex or Clomid) for 4–6 weeks with a prolactin management agent to address the progestogenic suppression introduced by the 19-nor nandrolone component. Blood work before and after PCT is recommended.

What weekly dosing is typical when using NTD 400 during a blast phase?

Most experienced users run NTD 400 at 400–800mg per week during a blast, split into two equal injections (e.g. Monday/Thursday). At 400mg/week, that equates to just 1ml per injection — one of the practical advantages of the 400mg/ml concentration compared to lower-concentration alternatives. Users newer to tri-ester blends typically start at the 400mg/week lower end before titrating upward.

How long does hormonal recovery typically take after a long blast with a nandrolone-containing compound?

Recovery timelines vary by individual, cycle length, and dosage, but nandrolone's progestogenic suppression generally extends recovery compared to testosterone-only cycles. Clinical observation and user-reported data suggest HPG axis recovery may take 3–6 months post-PCT in cases involving prolonged high-dose nandrolone use. Mid-PCT and post-PCT blood panels (LH, FSH, total testosterone) are the only reliable method for tracking actual recovery progress.

How should NTD 400 be stored in a 10ml vial after the first draw, and can it be administered with an insulin syringe?

After the first puncture, NTD 400 should be stored at room temperature (15–25°C), away from direct light, and must not be refrigerated — cold storage can cause precipitation of the high-concentration ester blend. Due to the 400mg/ml oil viscosity, standard insulin syringes are not recommended for drawing; use a 21G needle to draw and a 23–25G needle to inject. The rubber septum maintains sterility provided standard aseptic technique is applied between uses.

Why does the 400mg/ml concentration of NTD 400 matter during a blast-phase protocol?

At 400mg/ml, NTD 400 delivers the same milligram total in roughly half the oil volume compared to a 200mg/ml product. For users running blast-phase doses of 600–800mg/week, this difference is meaningful in terms of injection site comfort and total oil load per week. Fewer millilitres per injection reduces the risk of injection-site inflammation associated with high-volume oil-based administrations, making site rotation more manageable over multi-week blast phases. (2) angle_used

Manufacturer

GenTec's product portfolio is structured around a core principle of compositional specificity: rather than offering a single flagship compound per category, the brand maintains a tiered range within each major injectable class — single-ester monocompounds, dual-ester combinations, and multi-ester high-concentration blends — each positioned to serve a distinct administration context. NTD 400 sits at the top of GenTec's combination-product line, representing the brand's highest-concentration tri-ester offering in the nandrolone-inclusive blend category. This portfolio architecture reflects a deliberate commercial and technical strategy: multi-ester formulations at 400mg/ml require more rigorous solubility qualification than standard-concentration single-ester products, because each ester fraction must remain in stable co-solution across shelf-life without precipitation in the shared oil vehicle. GenTec's documented approach to this challenge involves qualification of carrier oil grade, co-solvent ratios, and ester fraction ordering during formulation development — a process that differentiates their high-concentration blend products from lower-specification alternatives in the same market segment. Within the NTD 400 line specifically, the formulation represents GenTec's application of that technical competency to the cruise & blast segment of the performance market, where end-users prioritise injection volume efficiency and pharmacokinetic predictability above all other product characteristics.